sorrento therapeutics
Sorrento, CHA Biotech To Develop Natural Killer Cell Therapies
The venture will develop and commercialize modified cellular therapies based on activated killer cell technology.
Sorrento, 3SBio Enter Immunotherapy Joint Venture In China
The joint venture agreement will develop and commercialize proprietary immunotherapies using chimeric antigen receptor T-cell technology.




